Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltitrexed and S-1 in Metastatic Colorectal Cancer
NCT02618356Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Dec 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltitrexed, tegafur in colorectal cancer (metastatic) (mCRC), sponsored by Fudan University. Status: unknown.
02
Drugs
raltitrexedtegafur
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT02618356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02618356.